Urology · Los Angeles, CA
NPI
1578547105
Since 2005
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
8635 W 3rd St, Suite 1 West
Los Angeles, CA, 90048
Phone (310) 854-9898
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.2M
43,802 services
Medicare patients, 2024
1,047
Average age 77
Drug cost, 2024
$963K
4,105 prescriptions
Company payments, 2025
$7,343
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew H Bui was code Q9967 (low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml), 2,400 times for 23 patients. In total Matthew H Bui billed 43,802 services in 135 codes, and Medicare paid $1.2M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2010-07-09.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 2,400 | 23 | $0.11 | $253 |
| 99214 Office E&M - Established | Office | 1,813 | 860 | $89.69 | $163K |
| 76775 Ultrasound - Abdomen and Pelvis | Office | 1,775 | 905 | $45.87 | $81K |
| J3260 Injection, tobramycin sulfate, up to 80 mg | Office | 1,426 | 186 | $1.88 | $2,678 |
| 81000 Clinical Chemistry | Office | 1,235 | 680 | $3.94 | $4,865 |
| 82570 Clinical Chemistry | Office | 1,234 | 679 | $5.08 | $6,267 |
| 76857 Ultrasound - Abdomen and Pelvis | Office | 1,143 | 666 | $36.56 | $42K |
| 36415 Venipuncture Blood Collection | Office | 1,094 | 670 | $8.65 | $9,462 |
| 80069 Clinical Chemistry | Office | 1,087 | 661 | $8.51 | $9,247 |
| 85025 Blood Count | Office | 1,070 | 655 | $7.60 | $8,136 |
| 80076 Clinical Chemistry | Office | 1,064 | 651 | $8.01 | $8,518 |
| 83036 Blood Count | Office | 1,055 | 645 | $9.52 | $10K |
| 84439 Clinical Chemistry | Office | 1,055 | 644 | $8.84 | $9,323 |
| 84443 Clinical Chemistry | Office | 1,054 | 643 | $16.45 | $17K |
| 84550 Clinical Chemistry | Office | 1,053 | 645 | $4.43 | $4,663 |
By year: 2022 $1.6M for 49,813 services; 2023 $1.4M for 44,620 services; 2024 $1.2M for 43,802 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81000 Clinical Chemistry | 1,235 | 680 | $3.94 | $4,865 |
| 82570 Clinical Chemistry | 1,234 | 679 | $5.08 | $6,267 |
| 36415 Venipuncture Blood Collection | 1,094 | 670 | $8.65 | $9,462 |
| 80069 Clinical Chemistry | 1,087 | 661 | $8.51 | $9,247 |
| 85025 Blood Count | 1,070 | 655 | $7.60 | $8,136 |
| 80076 Clinical Chemistry | 1,064 | 651 | $8.01 | $8,518 |
| 83036 Blood Count | 1,055 | 645 | $9.52 | $10K |
| 84439 Clinical Chemistry | 1,055 | 644 | $8.84 | $9,323 |
| 84443 Clinical Chemistry | 1,054 | 643 | $16.45 | $17K |
| 84550 Clinical Chemistry | 1,053 | 645 | $4.43 | $4,663 |
Medicare prescription drug claims, 2024
In 2024, the drug Matthew H Bui prescribed most often to Medicare patients was Tamsulosin Hcl, with 848 prescriptions and refills. In total Matthew H Bui wrote 4,105 Medicare prescriptions that cost $963K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 848 | 1,775 | 195 | $10K |
| Finasteride Generic | 723 | 1,651 | 179 | $9,191 |
| Dutasteride Generic | 417 | 939 | 120 | $13K |
| Silodosin Generic | 313 | 670 | 93 | $23K |
| Gemtesa Vibegron | 239 | 411 | 51 | $194K |
| Myrbetriq Mirabegron | 210 | 358 | 48 | $158K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 146 | 359 | 37 | $2,915 |
| Tadalafil Generic | 119 | 223 | 28 | $14K |
| Solifenacin Succinate Generic | 99 | 185 | 28 | $3,365 |
| Potassium Citrate Er Potassium Citrate | 98 | 226 | 28 | $14K |
| Cefuroxime Cefuroxime Axetil | 96 | 96 | 79 | $1,090 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 83 | 83 | 51 | $939 |
| Hydrochlorothiazide Generic | 64 | 122 | 14 | $176 |
| Dutasteride-Tamsulosin Dutasteride/Tamsulosin Hcl | 56 | 114 | 15 | $10K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 55 | 98 | 16 | $1,083 |
Brand drugs: - claims; generic drugs: 3,559 claims; opioid claims: 37.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew H Bui $7,343 ($7,343 in general payments such as food, travel and fees) from 21 companies. The largest payer was Intuitive Surgical, Inc. with $6,000.
| Company | Payments | Amount |
|---|---|---|
| Intuitive Surgical, Inc. ISRG | 4 | $6,000 |
| Janssen Biotech, Inc. JNJ | 8 | $181 |
| Abbvie Inc. ABBV | 6 | $171 |
| Teleflex LLC TFX | 4 | $141 |
| Dornier MedTech America, Inc | 1 | $102 |
| Telix Pharmaceuticals TLX | 3 | $100 |
| Ferring Pharmaceuticals Inc. | 5 | $96.25 |
| Urogen Pharma, Inc. URGN | 2 | $83.58 |
| Immunitybio, Inc. IBRX | 3 | $68.24 |
| Pfizer Inc. PFE | 4 | $66.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.